These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20225688)

  • 1. [Can oseltamivir (Tamiflu) be used in dialysis-requiring renal failure?].
    Rosenborg S
    Lakartidningen; 2010 Jan 20-26; 107(3):116-7. PubMed ID: 20225688
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
    Karie S; Launay-Vacher V; Janus N; Izzedine H; Deray G
    Nephrol Dial Transplant; 2006 Dec; 21(12):3606-8. PubMed ID: 16799172
    [No Abstract]   [Full Text] [Related]  

  • 3. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 4. Oseltamivir dosing in children undergoing hemodialysis.
    Schreuder MF; van der Flier M; Knops NB; Koster-Kamphuis L; Brüggemann RJ
    Clin Infect Dis; 2010 May; 50(10):1427-8. PubMed ID: 20397934
    [No Abstract]   [Full Text] [Related]  

  • 5. Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
    Brewster M; Smith JR; Dutkowski R; Robson R
    Vaccine; 2006 Nov; 24(44-46):6660-3. PubMed ID: 16797800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
    Robson R; Buttimore A; Lynn K; Brewster M; Ward P
    Nephrol Dial Transplant; 2006 Sep; 21(9):2556-62. PubMed ID: 16799169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamiflu: what dermatologists need to know.
    Bergstrom KG
    J Drugs Dermatol; 2010 Jan; 9(1):76-8. PubMed ID: 20120431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis.
    Patel K; Rayner CR; Giraudon M; Kamal MA; Morcos PN; Robson R; Kirkpatrick CM
    Br J Clin Pharmacol; 2015 Apr; 79(4):624-35. PubMed ID: 25289522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral therapy and prophylaxis for influenza in children.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Apr; 119(4):852-60. PubMed ID: 17403862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tamiflu, suicides and seasonal influenza].
    Nau JY
    Rev Med Suisse; 2007 Apr; 3(105):895. PubMed ID: 17514933
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropsychiatric concerns related to influenza treatment.
    Vantine M; Falahee ML; Vallerand AH
    Nurse Pract; 2009 Feb; 34(2):40-4. PubMed ID: 19155886
    [No Abstract]   [Full Text] [Related]  

  • 12. A caution about giving Tamiflu to children.
    Child Health Alert; 2009 Nov; 27():4-5. PubMed ID: 20050174
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of unwanted effects of oseltamivir carboxylate in juvenile rats after subcutaneous administration.
    Freichel C; Breidenbach A; Gand L; Toot J; Weiser T; Körner A; Singer T; Prinssen E; Hoffmann G
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):551-3. PubMed ID: 22145997
    [No Abstract]   [Full Text] [Related]  

  • 14. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
    [No Abstract]   [Full Text] [Related]  

  • 16. Oseltamivir and its active metabolite cross the placenta at significant levels.
    Meijer WJ; Bruinse HW; van den Broek MP; Kromdijk W; Wensing AM
    Clin Infect Dis; 2012 Jun; 54(11):1676-7. PubMed ID: 22460968
    [No Abstract]   [Full Text] [Related]  

  • 17. A concise and flexible synthesis of the potent anti-influenza agents tamiflu and tamiphosphor.
    Shie JJ; Fang JM; Wong CH
    Angew Chem Int Ed Engl; 2008; 47(31):5788-91. PubMed ID: 18613158
    [No Abstract]   [Full Text] [Related]  

  • 18. Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
    Ogihara T; Kano T; Wagatsuma T; Wada S; Yabuuchi H; Enomoto S; Morimoto K; Shirasaka Y; Kobayashi S; Tamai I
    Drug Metab Dispos; 2009 Aug; 37(8):1676-81. PubMed ID: 19439487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk.
    Eschenauer GA; Lam SW
    Intensive Care Med; 2011 Feb; 37(2):371. PubMed ID: 21103860
    [No Abstract]   [Full Text] [Related]  

  • 20. Oseltamivir for prophylaxis of influenza in vaccinated hemodialysis patients.
    Van Praet JT; Steyaert S; Demesmaecker M; Grootaert V; Reynders M
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):497-498. PubMed ID: 30767820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.